We identified a novel tumor suppressor PREX2, accounting for 22% of ESCCs with frequent somatic mutations or hyper-methylation, which promoted migration and invasion of ESCC cells in vitro. The gene discussed is PREX2; the disease is esophageal squamous cell carcinoma.